W3C home > Mailing lists > Public > public-bioschemas@w3.org > April 2019

Re: Question About Implementing BioSchema for Regenerative Medicine Site

From: Mark Liska <mliska@gobfw.com>
Date: Thu, 18 Apr 2019 14:43:08 +0000
To: "Gray, Alasdair J G" <A.J.G.Gray@hw.ac.uk>
CC: "public-bioschemas@w3.org" <public-bioschemas@w3.org>
Message-ID: <6DAD6CA1-98D3-4F0C-84C1-546F1E114BBA@gobfw.com>
Hey Alasdair – just checking in with you to see if you got my message!


_ _

Mark Liska
Digital Media Coordinator

bfw advertising + interactive
2500 North Military Trail, Suite 400
Boca Raton, FL 33431-6354

P 561.962.3336
http://www.gobfw.com<http://www.gobfw.com/>

This message contains confidential information and is intended only for the individual named. If you are not the named addressee you should not disseminate, distribute or copy this e-mail. Please notify the sender immediately by e-mail if you have received this e-mail by mistake and delete this e-mail from your system. E-mail transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or contain viruses. The sender therefore does not accept liability for any errors or omissions in the contents of this message, which arise as a result of e-mail transmission. If verification is required please request a hard-copy version. bfw advertising, 2500 North Military Trail, Suite 400, Boca Raton, Florida 33431-6354



From: Mark Liska <mliska@gobfw.com>
Date: Thursday, March 28, 2019 at 9:01 AM
To: "Gray, Alasdair J G" <A.J.G.Gray@hw.ac.uk>
Cc: "public-bioschemas@w3.org" <public-bioschemas@w3.org>
Subject: Re: Question About Implementing BioSchema for Regenerative Medicine Site

Hey Aladair, hope you have been well!

I contacted you a couple months ago to notify you that we have some pages that we are hoping to implement BioSchemas structured data on for a client, and I finally have those pages!

https://www.biostemtechnologies.com/products/vendaje-amniotic-membrane/



https://www.biostemtechnologies.com/products/rheo-flowable-allograft/



https://www.biostemtechnologies.com/products/vendaje-ac-amniotic-membrane/



https://www.biostemtechnologies.com/products/vendaje-optic-amniotic-membrane/



I would really appreciate any guidance you and your team could offer regarding implementing structured data here, because the FDA and the existing schema really clash about whether these products constitute “Medical Entities.”

If you would like to call me and talk about this I would gladly make time to hear your thoughts. And, of course, anything we do could be put up on bioschemas.org as an example (provided our client doesn’t have a problem with it – I don’t think they would)!

My office line is 561-962-3336 if you would like to talk about any of this.

Thanks, Alasdair!

-Mark Liska

_ _

Mark Liska
Digital Media Coordinator

bfw advertising + interactive
2500 North Military Trail, Suite 400
Boca Raton, FL 33431-6354

P 561.962.3336
http://www.gobfw.com<http://www.gobfw.com/>

This message contains confidential information and is intended only for the individual named. If you are not the named addressee you should not disseminate, distribute or copy this e-mail. Please notify the sender immediately by e-mail if you have received this e-mail by mistake and delete this e-mail from your system. E-mail transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or contain viruses. The sender therefore does not accept liability for any errors or omissions in the contents of this message, which arise as a result of e-mail transmission. If verification is required please request a hard-copy version. bfw advertising, 2500 North Military Trail, Suite 400, Boca Raton, Florida 33431-6354



From: Mark Liska <mliska@gobfw.com>
Date: Monday, February 18, 2019 at 9:05 AM
To: "Gray, Alasdair J G" <A.J.G.Gray@hw.ac.uk>
Cc: "public-bioschemas@w3.org" <public-bioschemas@w3.org>
Subject: Re: Question About Implementing BioSchema for Regenerative Medicine Site

Alasdair,

The site is currently in development, so I am not sure I would even be allowed to share the copy deck that has been prepared for it due t confidentiality concerns.

What I can do, though, is let you know when the site goes live and circle back around with you to get your thoughts on updating some types/properties.

Does that work for you?

Thanks for your time!

-Mark


_ _

Mark Liska
Digital Media Coordinator

bfw advertising + interactive
2500 North Military Trail, Suite 400
Boca Raton, FL 33431-6354

P 561.962.3336
http://www.gobfw.com<http://www.gobfw.com/>

This message contains confidential information and is intended only for the individual named. If you are not the named addressee you should not disseminate, distribute or copy this e-mail. Please notify the sender immediately by e-mail if you have received this e-mail by mistake and delete this e-mail from your system. E-mail transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or contain viruses. The sender therefore does not accept liability for any errors or omissions in the contents of this message, which arise as a result of e-mail transmission. If verification is required please request a hard-copy version. bfw advertising, 2500 North Military Trail, Suite 400, Boca Raton, Florida 33431-6354



From: "Gray, Alasdair J G" <A.J.G.Gray@hw.ac.uk>
Date: Monday, February 18, 2019 at 8:59 AM
To: Mark Liska <mliska@gobfw.com>
Cc: "public-bioschemas@w3.org" <public-bioschemas@w3.org>
Subject: Re: Question About Implementing BioSchema for Regenerative Medicine Site

Hi Mark,

Thanks for your message. This looks to be an interesting use case for Bioschemas. Would you be able to point to some example pages that you would be looking to mark up? That would give us a better idea of whether the extension we are currently proposing would meet your needs.

Best regards,

Alasdair




On 15 Feb 2019, at 15:17, Mark Liska <mliska@gobfw.com<mailto:mliska@gobfw.com>> wrote:

Hello, my name is Mark Liska and I work for an advertising agency in Florida.

I’m working on writing structured data for a client that produces regenerative medicine, biologics, & related therapies.

Would any of the following items be eligible to be marked up by BioSchema structured data?

Regenerative Medicine, placentally-derived products, human tissue products, the names of the placentally-derived products themselves (the FDA does not consider human tissue products to be drugs)?

Thank you for any time you can devote to answering my question!

-Mark Liska

_ _

Mark Liska
Digital Media Coordinator

bfw advertising + interactive
2500 North Military Trail, Suite 400
Boca Raton, FL 33431-6354

P 561.962.3336
http://www.gobfw.com<http://www.gobfw.com/>

This message contains confidential information and is intended only for the individual named. If you are not the named addressee you should not disseminate, distribute or copy this e-mail. Please notify the sender immediately by e-mail if you have received this e-mail by mistake and delete this e-mail from your system. E-mail transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or contain viruses. The sender therefore does not accept liability for any errors or omissions in the contents of this message, which arise as a result of e-mail transmission. If verification is required please request a hard-copy version. bfw advertising, 2500 North Military Trail, Suite 400, Boca Raton, Florida 33431-6354

--
Alasdair J G Gray
Associate Professor in Computer Science,
School of Mathematical and Computer Sciences
Heriot-Watt University, Edinburgh, UK.

Email: A.J.G.Gray@hw.ac.uk<mailto:A.J.G.Gray@hw.ac.uk>
Web: http://www.macs.hw.ac.uk/~ajg33
ORCID: http://orcid.org/0000-0002-5711-4872
Office: Earl Mountbatten Building 1.39
Twitter: @gray_alasdair

To arrange a meeting: http://doodle.com/ajggray

________________________________

Heriot-Watt University is The Times & The Sunday Times International University of the Year 2018

Founded in 1821, Heriot-Watt is a leader in ideas and solutions. With campuses and students across the entire globe we span the world, delivering innovation and educational excellence in business, engineering, design and the physical, social and life sciences. This email is generated from the Heriot-Watt University Group, which includes:
1.       Heriot-Watt University, a Scottish charity registered under number SC000278
2.       Edinburgh Business School a Charity Registered in Scotland, SC026900. Edinburgh Business School is a company limited by guarantee, registered in Scotland with registered number SC173556 and registered office at Heriot-Watt University Finance Office, Riccarton, Currie, Midlothian, EH14 4AS
3.       Heriot- Watt Services Limited (Oriam), Scotland's national performance centre for sport. Heriot-Watt Services Limited is a private limited company registered is Scotland with registered number SC271030 and registered office at Research & Enterprise Services Heriot-Watt University, Riccarton, Edinburgh, EH14 4AS.

The contents (including any attachments) are confidential. If you are not the intended recipient of this e-mail, any disclosure, copying, distribution or use of its contents is strictly prohibited, and you should please notify the sender immediately and then delete it (including any attachments) from your system.
Received on Thursday, 18 April 2019 14:49:36 UTC

This archive was generated by hypermail 2.4.0 : Friday, 17 January 2020 19:08:08 UTC